New and innovative avenues for the investigation and treatment of demyelinating disorders are required that involve autophagy, apoptosis, FoxOs, mTOR, AMPK, SIRT1, and related systems with the APOE-ε4 gene and SARS-CoV-2. The gene discussed is MTOR; the disease is demyelinating disease.